J
Judit Anido
Researcher at Hebron University
Publications - 15
Citations - 2632
Judit Anido is an academic researcher from Hebron University. The author has contributed to research in topics: Cancer & Leukemia inhibitory factor. The author has an hindex of 8, co-authored 13 publications receiving 2452 citations. Previous affiliations of Judit Anido include Autonomous University of Barcelona.
Papers
More filters
Journal ArticleDOI
Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer
Maurizio Scaltriti,Federico Rojo,Alberto Ocaña,Judit Anido,Marta Guzman,Javier Cortes,Serena Di Cosimo,Xavier Matias-Guiu,Santiago Ramón y Cajal,Joaquín Arribas,José Baselga +10 more
TL;DR: Breast tumors that express p95HER2 are resistant to trastuzumab and may require alternative or additional anti-HER2-targeting strategies, and women with HER2-overexpressing breast cancers that express this receptor should be responsive to these agents.
Journal ArticleDOI
TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma
Judit Anido,Andrea Sáez-Borderías,Alba Gonzalez-Junca,Laura Rodon,Gerard Folch,Maria Ángeles Carmona,Rosa M. Prieto-Sánchez,Ignasi Barba,Elena Martínez-Sáez,Ludmila Prudkin,Isabel Cuartas,C. Raventós,Francisco Martínez-Ricarte,M. Antonia Poca,David Garcia-Dorado,Michael Lahn,Jonathan M. Yingling,Jordi Rodon,Juan Sahuquillo,Juan Sahuquillo,José Baselga,Joan Seoane,Joan Seoane +22 more
TL;DR: A cell population enriched for GICs that expresses high levels of CD44 and Id1 and tend to be located in a perivascular niche is identified, which confer poor prognosis in GBM patients.
Journal ArticleDOI
TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma.
Silvia Peñuelas,Judit Anido,Rosa M. Prieto-Sánchez,Gerard Folch,Ignasi Barba,Isabel Cuartas,David Garcia-Dorado,M. Antonia Poca,Juan Sahuquillo,Juan Sahuquillo,José Baselga,José Baselga,Joan Seoane +12 more
TL;DR: The results show that TGF-beta and LIF have an essential role in the regulation of GICs in human glioblastoma.
Journal Article
Activated Extracellular Signal-regulated Kinases: Association with Epidermal Growth Factor Receptor/Transforming Growth Factor α Expression in Head and Neck Squamous Carcinoma and Inhibition by Anti-Epidermal Growth Factor Receptor Treatments
Joan Albanell,Jordi Codony-Servat,Federico Rojo,Jose Maria Del Campo,Silvia Sauleda,Judit Anido,Guillermo Raspall,Jordi Giralt,José Roselló,Robert Ian Nicholson,John Mendelsohn,José Baselga +11 more
TL;DR: Support is provided for a role of activation of ERK1/2 in head and neck squamous carcinoma and a correlation with EGF receptor/TGF-alpha expression as potential surrogate markers of EGF-receptor signaling in clinical therapeutic studies.
Journal Article
ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells.
Judit Anido,Pablo Matar,Joan Albanell,Marta Guzman,Federico Rojo,Joaquín Arribas,Steve Averbuch,José Baselga +7 more
TL;DR: The effects of ZD1839 in breast cancer cell lines expressing different levels of EGFR and the closely related HER2 receptor suggest that there is a strong rationale to conduct clinical trials of the tyrosine kinase inhibitor in patients with HER2-overexpressing breast tumors.